Physician profile
Daniel A Charen
NPI 1124473491
$20,416.79
in general payments reported to CMS, 2019-2025
9 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,850 · 2022: $15K · 2023: $364 · 2024: $233 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $9,688.86 | 2021-2022 | |
| Seapearl East, INC | $3,897.40 | 2022-2025 | |
| Arthrex, INC. | $3,408.89 | 2022 | |
| Smith+Nephew, INC. | $3,102.93 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Acufex |
| Pylant Medical | $166.25 | 2022 | |
| Ferring Pharmaceuticals INC. | $70.00 | 2024 | Euflexxa |
| Depuy Synthes Sales INC. | $34.47 | 2023 | Va-Lcp, Tfn-Advance |
| Dynasplint Systems INC. | $29.14 | 2025 | Dynasplint |
| Gotham Surgical Solutions & Devices, INC. | $18.85 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Charen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.